Archives

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP
Market Updates

Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP

May 12, 2025 Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted in...

  • May 12, 2025 05:30 AM PDT
  • EODHD
Global Markets React to Diplomatic Updates, U.S. Indices Dip, Nikkei 225 and Nifty 50 Edge Higher
Market Updates

Global Markets React to Diplomatic Updates, U.S. Indices Dip, Nikkei 225 and Nifty 50 Edge Higher

Highlights:,Diplomatic signals from U.S.–China and Russia–Ukraine discussions impact market sentiment,Asian indices including ASX 200, Nikkei 225, Kospi, and Nifty 50 open the week in green territory,U.S. pharmaceutical sector in focus after executive ord...

Novo Nordisk Tumbles as Lilly's  Zepbound Shows Greater Weight Loss in Trial
Market Updates

Novo Nordisk Tumbles as Lilly's Zepbound Shows Greater Weight Loss in Trial

Novo Nordisk (NYSE:NVO) shares dropped 5% in early trading on Monday after Eli Lilly (NYSE:LLY) released new trial data showing its weight loss drug, Zepbound, delivered stronger results than Wegovy....

  • May 12, 2025 05:16 AM PDT
  • EODHD
Stellantis eyes November for start of hybrid Fiat 500 production
Market Updates

Stellantis eyes November for start of hybrid Fiat 500 production

ROME (Reuters) -Automaker Stellantis aims to start producing the hybrid version of its Fiat 500 city car in November, it said on Monday. The model, built at the historic Mirafiori plant in Turin, is m...

  • May 12, 2025 05:01 AM PDT
  • EODHD
CPS Technologies to Participate in Sidoti Microcap Virtual Conference
Market Updates

CPS Technologies to Participate in Sidoti Microcap Virtual Conference

NORTON, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- CPS Technologies Corporation (NASDAQ:CPSH) (“CPS” or the “Company”) today announced that, as it did last year, the Company will participate in the Sidot...

  • May 12, 2025 05:00 AM PDT
  • EODHD
Amazon Stock Surges. Why It’s a Mag 7 Outperformer on Tariffs Deal.
Market Updates

Amazon Stock Surges. Why It’s a Mag 7 Outperformer on Tariffs Deal.

Amazon was outstripping its Magnificent Seven peers such as Microsoft, Alphabet and Meta Platforms as the market welcomed news of a U.S.-China truce on tariffs. Continue Reading View Comments

  • May 12, 2025 04:38 AM PDT
  • EODHD
Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks
Market Updates

Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks

Drugmakers' shares fell globally after President Trump said he would sign an executive order to lower the cost of prescription drugs. Shares of Japan's Daiichi Sankyo, which gets about a third of reve...

  • May 12, 2025 04:33 AM PDT
  • EODHD
Inter&Co Inc. Reports Year-Over-Year Net Income Growth of 57%
Market Updates

Inter&Co Inc. Reports Year-Over-Year Net Income Growth of 57%

BELO HORIZONTE, Brazil, May 12, 2025 (GLOBE NEWSWIRE) -- Inter&Co Inc. (NASDAQ: INTR | B3: INBR32), the leading financial super app providing financial and digital commerce services to 37.7 million cu...

  • May 12, 2025 04:33 AM PDT
  • EODHD
SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
Market Updates

SciSparc-Clearmind Collaboration Leads to Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

TEL AVIV, Israel, May 12, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to...

  • May 12, 2025 04:32 AM PDT
  • EODHD
Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction
Market Updates

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

Patent publication in Europe strengthens Clearmind’s global IP position and advances strategic focus on addiction treatment Vancouver, Canada, May 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc....

  • May 12, 2025 04:32 AM PDT
  • EODHD
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.